Bain Capital Life Sciences Investors’s Aclaris Therapeutics ACRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
-1,000,000
| Closed | -$1.1M | – | 25 |
|
|
2024
Q2 | $1.1M | Sell |
1,000,000
-2,000,000
| -67% | -$2.2M | 0.12% | 24 |
|
|
2024
Q1 | $3.72M | Sell |
3,000,000
-500,000
| -14% | -$620K | 0.3% | 24 |
|
|
2023
Q4 | $3.68M | Buy |
3,500,000
+100,000
| +3% | +$105K | 0.35% | 25 |
|
|
2023
Q3 | $23.3M | Hold |
3,400,000
| – | – | 2.6% | 11 |
|
|
2023
Q2 | $35.3M | Hold |
3,400,000
| – | – | 3.63% | 8 |
|
|
2023
Q1 | $27.5M | Buy |
+3,400,000
| New | +$27.5M | 3.44% | 10 |
|